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Do steroid injections 
help with osteoarthritis 
of the knee?
■ EVIDENCE-BASED ANSWER 
Intra-articular steroid injections appear to provide
2 to 6 weeks of pain relief for patients with knee
osteoarthritis (strength of recommendation [SOR]:
A). Higher-dose steroids with or without joint
lavage can provide pain relief up to 24 weeks
(SOR: A). Steroid injections may be an appropriate
adjunct in the treatment of osteoarthritis, which
includes nonpharmacologic treatments (education,
weight loss, physical therapy) and pharmacologic
therapy (nonsteroidal anti-inflammatory drugs
[NSAIDs], topical and opioid analgesics).1,2
■ EVIDENCE SUMMARY
Osteoarthritis, also known as degenerative joint dis-
ease, is the most prevalent form of arthritis in the
United States.3 For the elderly, it is a common cause
of pain and disability, affecting patients’ ability to
perform activities of daily living. Common causes of
osteoarthritis include past and present biomechani-
cal stresses affecting the articular cartilage, sub-
chondral bone changes, and biochemical changes in
the articular cartilage and synovial membrane.3
Treatment of patients with osteoarthritis of the
knee should be individualized to the severity of
symptoms for each patient. A treatment plan can
include patient education, physical and occupa-
tional therapy, non-opioid oral and topical agents,
NSAIDs, intra-articular corticosteroid injections,
viscosupplementation injections, arthroscopic
lavage, and total knee replacements. 
Our knowledge of the long-term safety and effi-
cacy of intra-articular knee corticosteroid injec-
tion is based on limited data. In a randomized,
double-blind, placebo-controlled crossover study,
investigators randomized 59 patients aged 51 to
89 years to receive either an intra-articular injec-
tion of 1 mL of 40 mg methylprednisolone or 1 mL
of 0.9% saline. After 3 weeks, patients receiving
steroid injection had a minimal change in baseline
visual analogue score for pain compared with
those receiving saline (median change: –2.0 mm
vs 0 mm on a 100-mm scale).4
A randomized, single-blinded study involving
84 patients demonstrated significant self-report-
ed “overall improvement” for patients given
intra-articular triamcinolone hexacetonide
(78%) compared with placebo (49%) after 1
week (P<.05).5 It also confirmed reports that
visual analogue score for pain and distance
walked in 1 minute improves significantly for
both steroid- and placebo-treated groups up to 6
weeks. Only the steroid-treated patients exhibit-
ed improved walking distance at 1 week com-
pared with baseline (P<.001).
A recent randomized, double-blind, placebo-con-
trolled trial studied the long-term safety and effica-
cy of treatment of knee osteoarthritis with repeat-
ed steroid injections.6 These investigators studied
66 patients aged 40 to 80 years recruited from
rheumatology clinics. One half (n=33) received
injections of triamcinolone acetonide 40 mg, and
the other half received saline injections every 3
months for 2 years. At 1- and 2-year interval follow-
ups, no statistically significant difference was seen
between the 2 groups in loss of joint space and no
progression of degenerative disease, as demon-
strated by measurements of joint space widths by
standardized fluoroscopically guided radiographs.
Although the primary outcome measure of this
study was to assess radiologic joint space narrow-
ing with repeated injections, knee pain and stiff-
ness appeared to improve after 2 years, although
these results were not well quantified.
A limitation of most studies testing intra-
articular therapy has been sample size.
Combining studies may allow the ability to
detect levels of pain relief not found in individual
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studies. A recent meta-analysis of 6 randomized
controlled trials using intra-articular corticos-
teroid knee injections found short-term relief of
pain for 2 weeks (relative risk [RR]=1.66; 95%
confidence interval [CI], 1.37–2.01).7 The num-
ber needed to treat (NNT) range for these stud-
ies is 1.3 to 3.5. Two additional studies included
in this study using higher-dose steroids (pred-
nisone equivalent dose of 37.5 to 80 mg), with or
without joint lavage, assessed improvement at
16 to 24 weeks. Although neither individual
study showed statistically significant differ-
ences, the pooled data from the 2 studies favored
symptom improvement at 16 to 24 weeks
(RR=2.09; 95% CI, 1.2–3.7; NNT=4.4).7
■ RECOMMENDATIONS FROM OTHERS
Guidelines for the treatment of knee
osteoarthritis were outlined by a task force for
the European League Against Rheumatism
(EULAR) Standing Committee for Clinical
Trials. The task force recommended intra-artic-
ular steroid injection for acute exacerbation of
knee pain. This task force performed an evi-
dence-based review and concluded at least 1
randomized control trial recommended intra-
articular steroid for patients with osteoarthritis.
It was noted that intra-articular steroid injec-
tions were effective for only short-term pain
relief and that there are no predictors of success
of treatment, such as the presence or absence of
such factors as joint effusion, degree of radio-
logic change, age, or obesity.2
The American College of Rheumatology
Subcommittee on Osteoarthritis Guidelines devel-
oped both nonpharmacological and pharmacologi-
cal recommendations for the treatment of
osteoarthritis of the knee.8 These recommenda-
tions include: use of intra-articular steroid injec-
tion for patients with acute exacerbations who
had evidence for joint inflammation, and joint
aspiration accompanying the intra-articular injec-
tion for “short-term relief.” 
Luis C. Palacios, MD, Wanwisa Y. Jones, MD, Helen
G. Mayo, MLS, University of Texas Southwestern, Dallas
■ CLINICAL COMMENTARY
Intra-articular steroids provide extra relief
for patients with acute exacerbations
This well-constructed review demonstrates
that intra-articular steroid injections provide
up to 3 weeks of pain relief for patients with
osteoarthritis of the knee. While this may not
seem like much, in practice it can be quite help-
ful in some situations. It provides supplemen-
tal pain relief for patients with acute exacerba-
tions of their disease. It is also useful as a 
temporizing measure for patients who are can-
didates for total knee replacement but are not
quite ready for it psychologically.
Wail Malaty, MD, Hendersonville Family Practice
Residency Program, Hendersonville, NC
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Intra-articular steroids are useful for
candidates for total knee replacement
who are not ready psychologically
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